Insiders · ATAI

ATAI insider transactions

AtaiBeckley Inc. (ATAI) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for ATAI

• 6h
  SEC Form 4 filed by Director Angermayer Christian

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 6h
  SEC Form 4 filed by Director Braunstein Scott

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 6h
  SEC Form 4 filed by Director Fischer Laurent

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 6h
  SEC Form 4 filed by Director Kalali Amir H

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 6h
  SEC Form 4 filed by Director Hoffman John Francis

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 6h
  SEC Form 4 filed by Director Smiley Andrea Heslin

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 6h
  SEC Form 4 filed by Director Johnson Sabrina Martucci

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 6h
  SEC Form 4 filed by Director Hershberg Robert

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 47d
  SEC Form 4 filed by Craig Kevin James

  4 - AtaiBeckley Inc. (0002081043) (Issuer)
• 194d
  SEC Form 4 filed by Director Feilding-Mellen Cosmo

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 214d
  SEC Form 4 filed by Director Hershberg Robert

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 214d
  Director Feilding-Mellen Cosmo was granted 7,702,990 shares (SEC Form 4)

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 214d
  SEC Form 4 filed by Director Braunstein Scott

  4 - Atai Beckley N.V. (0001840904) (Issuer)
• 214d
  SEC Form 3 filed by new insider Hershberg Robert

  3 - Atai Beckley N.V. (0001840904) (Issuer)
• 214d
  SEC Form 3 filed by new insider Feilding-Mellen Cosmo

  3 - Atai Beckley N.V. (0001840904) (Issuer)
• 248d
  SEC Form 4 filed by Officer Barrett Christopher Ryan Cave

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 248d
  New insider Barrett Christopher Ryan Cave claimed ownership of 155,066 shares (SEC Form 3)

  3 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 249d
  Large owner Apeiron Investment Group Ltd. converted options into 2,367,200 shares (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 294d
  Large owner Apeiron Investment Group Ltd. bought $19,000,000 worth of shares (8,675,799 units at $2.19) (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 297d
  SEC Form 4 filed by Officer Rao Srinivas

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 346d
  SEC Form 4 filed by Director Hoffman John Francis

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 346d
  SEC Form 4 filed by Director Johnson Sabrina Martucci

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 346d
  SEC Form 4 filed by Director Kalali Amir H

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 346d
  SEC Form 4 filed by Director Smiley Andrea Heslin

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 346d
  SEC Form 4 filed by Director Braunstein Scott

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 346d
  SEC Form 4 filed by Director Fischer Laurent

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 346d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 369d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 381d
  SEC Form 3 filed by new insider Hoffman John Francis

  3 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 441d
  Chief Scientific Officer Short Glenn Frank sold $17,767 worth of shares (13,161 units at $1.35), decreasing direct ownership by 24% to 42,333 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 441d
  Chief Business Officer Kirpekar Sahil sold $65,560 worth of shares (48,563 units at $1.35), decreasing direct ownership by 30% to 115,636 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 441d
  Chief Financial Officer Johnson Anne Nagengast sold $45,286 worth of shares (33,545 units at $1.35), decreasing direct ownership by 19% to 140,045 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 441d
  Officer Rao Srinivas sold $101,814 worth of shares (75,418 units at $1.35), decreasing direct ownership by 26% to 212,942 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 441d
  Chief Medical Officer Craig Kevin James sold $15,610 worth of shares (11,563 units at $1.35), decreasing direct ownership by 58% to 8,437 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 441d
  Large owner Apeiron Investment Group Ltd. bought $2,520,000 worth of shares (1,800,000 units at $1.40) (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 446d
  Officer Rao Srinivas converted options into 175,000 shares, increasing direct ownership by 154% to 288,360 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 446d
  Chief Scientific Officer Short Glenn Frank converted options into 32,500 shares, increasing direct ownership by 141% to 55,494 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 446d
  Chief Medical Officer Craig Kevin James converted options into 20,000 shares (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 446d
  Chief Business Officer Kirpekar Sahil converted options into 100,000 shares, increasing direct ownership by 156% to 164,199 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 446d
  Chief Financial Officer Johnson Anne Nagengast converted options into 100,000 shares, increasing direct ownership by 136% to 173,590 units (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 459d
  SEC Form 4 filed by Chief Scientific Officer Short Glenn Frank

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 459d
  SEC Form 4 filed by Chief Medical Officer Craig Kevin James

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 460d
  SEC Form 4 filed by Chief Financial Officer Johnson Anne Nagengast

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 474d
  Large owner Apeiron Investment Group Ltd. bought $22,755,008 worth of shares (10,835,718 units at $2.10) (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 514d
  SEC Form 4 filed by Officer Rao Srinivas

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 514d
  SEC Form 3 filed by new insider Craig Kevin James

  3 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 514d
  New insider Short Glenn Frank claimed ownership of 22,994 shares (SEC Form 3)

  3 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 521d
  SEC Form 4 filed by Chief Operating Officer Kochendoerfer Gerd

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 542d
  SEC Form 3 filed by new insider Kochendoerfer Gerd

  3 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 612d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 612d
  SEC Form 4 filed by Chief Financial Officer Johnson Anne Nagengast

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 612d
  SEC Form 4 filed by Officer Brand Florian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 612d
  SEC Form 4 filed by Officer Rao Srinivas

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 619d
  Large owner Atai Life Sciences N.V. sold $16,093,000 worth of Ordinary Shares (2,660,000 units at $6.05) (SEC Form 4)

  4 - ATAI Life Sciences N.V. (0001840904) (Reporting)
• 724d
  SEC Form 4 filed by Director Auerbach Michael

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 724d
  SEC Form 4 filed by Director Angermayer Christian

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 724d
  SEC Form 4 filed by Director Braunstein Scott

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 724d
  SEC Form 4 filed by Director Kalali Amir H

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 724d
  SEC Form 4 filed by Director Fischer Laurent

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)
• 724d
  SEC Form 4 filed by Director Smiley Andrea Heslin

  4 - ATAI Life Sciences N.V. (0001840904) (Issuer)